- Home
- AUST vs TLPH Comparison
AUST vs TLPH Comparison
Compare AUST & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AUST
- TLPH
- Stock Information
- Founded
- AUST 2020
- TLPH 2005
- Country
- AUST Canada
- TLPH United States
- Employees
- AUST N/A
- TLPH N/A
- Industry
- AUST
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- AUST
- TLPH Health Care
- Exchange
- AUST Nasdaq
- TLPH Nasdaq
- Market Cap
- AUST 15.5M
- TLPH 12.7M
- IPO Year
- AUST 2022
- TLPH 2011
- Fundamental
- Price
- AUST $1.25
- TLPH $0.71
- Analyst Decision
- AUST
- TLPH Strong Buy
- Analyst Count
- AUST 0
- TLPH 2
- Target Price
- AUST N/A
- TLPH $4.50
- AVG Volume (30 Days)
- AUST 92.5K
- TLPH 111.1K
- Earning Date
- AUST 03-03-2025
- TLPH 03-05-2025
- Dividend Yield
- AUST N/A
- TLPH N/A
- EPS Growth
- AUST N/A
- TLPH N/A
- EPS
- AUST N/A
- TLPH N/A
- Revenue
- AUST N/A
- TLPH $281,000.00
- Revenue This Year
- AUST N/A
- TLPH N/A
- Revenue Next Year
- AUST N/A
- TLPH N/A
- P/E Ratio
- AUST N/A
- TLPH N/A
- Revenue Growth
- AUST N/A
- TLPH N/A
- 52 Week Low
- AUST $0.62
- TLPH $0.50
- 52 Week High
- AUST $3.19
- TLPH $1.61
- Technical
- Relative Strength Index (RSI)
- AUST 46.23
- TLPH 59.08
- Support Level
- AUST $1.05
- TLPH $0.55
- Resistance Level
- AUST $1.27
- TLPH $0.64
- Average True Range (ATR)
- AUST 0.10
- TLPH 0.07
- MACD
- AUST 0.03
- TLPH 0.02
- Stochastic Oscillator
- AUST 64.82
- TLPH 92.42
About AUST Austin Gold Corp.
Austin Gold Corp is a gold exploration and development company focused on gold targets and making district-scale gold discoveries in Nevada. Exploration and development of mineral projects is considered the Company's single business segment. Its projects include Kelly Creek in Humboldt County, Lone Mountain and Miller in Elko County, and Fourmile Basin in Nye County.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.